---
schema_version: "secwatch.filing_event.v1"
accession: "0001490978-26-000036"
form_type: "8-K"
ticker: "SDGR"
cik: "0001490978"
company_name: "Schrodinger, Inc."
filed_at: "2026-05-05T23:59:59+00:00"
generated_at: "2026-05-14T23:20:19.427348+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Schrödinger Q1 ACV $28.4M (+12%), drug disc. rev surges to $22.9M, net loss $60M, FY guide maintained

## Summary
- ACV $28.4M (+12% YoY); software revenue $35.6M (-21%) reflecting hosted transition.
- Drug discovery revenue surged to $22.9M from $10.2M on deferred revenue recognition and program discontinuation.
- Net loss $60.0M vs $59.8M; cash and securities $406M.
- Maintained FY2026 guidance: ACV $218-228M (10-15% growth), drug discovery revenue $55-65M.
- Planned summer launch of Bunsen agentic AI co-scientist; Lilly's $2.3B Ajax acquisition validates platform.

## SEC filing metadata
- accession: 0001490978-26-000036
- form_type: 8-K
- ticker: SDGR
- cik: 0001490978
- company_name: Schrodinger, Inc.
- filed_at: 2026-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1490978/000149097826000036/0001490978-26-000036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1490978/000149097826000036/sdgr-20260505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001490978-26-000036
- JSON: https://secwatch.observer/filing/0001490978-26-000036.json
- Plain text: https://secwatch.observer/filing/0001490978-26-000036.txt

## Key facts
- Earnings Releases
  Schrodinger, Inc. reported financial results for first quarter ended March 31, 2026.
  - Period: first quarter ended March 31, 2026
  - Result: reported results
  source text: On May 5, 2026, Schrödinger, Inc. (the “Company”) issued a press release announcing its financial results for the first quarter ended March 31, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1490978/000149097826000036/0001490978-26-000036-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.